Michael G. Kauffman

2017

In 2017, Michael G. Kauffman earned a total compensation of $2.7M as Chief Executive Officer at Karyopharm Therapeutics, a 73% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$251,503
Option Awards$1,857,650
Salary$530,500
Other$11,460
Total$2,651,113

Kauffman received $1.9M in option awards, accounting for 70% of the total pay in 2017.

Kauffman also received $251.5K in non-equity incentive plan, $530.5K in salary and $11.5K in other compensation.

Rankings

In 2017, Michael G. Kauffman's compensation ranked 4,190th out of 14,666 executives tracked by ExecPay. In other words, Kauffman earned more than 71.4% of executives.

ClassificationRankingPercentile
All
4,190
out of 14,666
71st
Division
Manufacturing
1,467
out of 5,772
75th
Major group
Chemicals And Allied Products
420
out of 2,075
80th
Industry group
Drugs
321
out of 1,731
82nd
Industry
Pharmaceutical Preparations
255
out of 1,333
81st
Source: SEC filing on April 27, 2018.

Kauffman's colleagues

We found two more compensation records of executives who worked with Michael G. Kauffman at Karyopharm Therapeutics in 2017.

2017

Sharon Shacham

Karyopharm Therapeutics

Chief Scientific Officer

2017

Christopher Primiano

Karyopharm Therapeutics

General Counsel

News

In-depth

You may also like